| AUC | Area under the curve |
| ATS/ERS | American Thoracic Society/European Respiratory Society |
| BASE | Base model |
| BMP | Bronchial mucus plugs |
| BO | Bronchiolitis obliterans |
| CAP | Community-acquired pneumonia |
| CI | Confidence interval |
| CRP | C-reactive protein |
| CT | Computed tomography |
| DCA | Decision curve analysis |
| ESR | Erythrocyte sedimentation rate |
| EXT | Extended model |
| FEF25% | Forced expiratory flow at 25% of forced vital capacity |
| FEF50% | Forced expiratory flow at 50% of forced vital capacity |
| FEF75% | Forced expiratory flow at 75% of forced vital capacity |
| FEV1 | Forced expiratory volume in 1 s |
| FVC | Forced vital capacity |
| IFN | Interferon |
| IL | Interleukin |
| IQR | Interquartile range |
| LASSO | Least absolute shrinkage and selection operator |
| LDH | Lactate dehydrogenase |
| MAE | Mean absolute error |
| MICE | Multiple imputation by chained equations |
| MMEF | Maximal mid-expiratory flow |
| MPP | Mycoplasma pneumoniae pneumonia |
| M. pneumoniae | Mycoplasma pneumoniae |
| NK | Natural killer |
| OR | Odds ratio |
| PA | Particle agglutination |
| PB | Plastic bronchitis |
| PCR | Polymerase chain reaction |
| PIBO | Post-infectious bronchiolitis obliterans |
| ROC | Receiver operating characteristic |
| RMPP | Refractory Mycoplasma pneumoniae pneumonia |
| SAD | Small airway dysfunction |
| sIL-2R | Soluble interleukin-2 receptor |
| SMPP | Severe Mycoplasma pneumoniae pneumonia |
| Treg | Regulatory T cells |
| Th | T-helper |